Prof. Dr. med. Frank Gansauge

Prof. Dr. med. Frank Gansauge is an experienced, highly skilled oncologist specializing in immunotherapy and dendritic cell cancer vaccines. With over three decades of experience, he has a solid academic background, having studied human medicine at the Universities of Tübingen and Cardiff. He obtained a medical license and completed his surgical residency at Ulm University Hospital, where he later specialized in surgical oncology. Prof. Gansauge's impressive career includes additional qualifications in chemotherapy and follow-up oncological therapy. He has also received recognition for his contributions, including the Fred Stephans Award in 1995 and the Merckle Research Award in 1999. Furthermore, he has been invited to speak at international symposiums on stem cell and regenerative medicine, highlighting his expertise in the field. Prof. Gansauge is the Senior Physician and Head of the day clinic and research laboratory at the Ulm University Hospital. He is also the Managing Director of the Department of Oncology, immunotherapy, and dendritic cells at the LDG Laboratory of Dr. Gansauge Ulm. With his extensive knowledge and dedication to research, Prof. Dr. med. Frank Gansauge is highly regarded in oncology. His focus on immunotherapy and dendritic cell cancer vaccines demonstrates his commitment to developing innovative, effective treatments for his patients. With a strong academic background and numerous publications, patients can trust they receive expert care from a renowned medical professional.